missing translation for 'onlineSavingsMsg'
Läs mer
Läs mer
Tocris Bioscience™ BMS 303141

Description
ATP citrate lyase (ACL) inhibitor (IC50 = 0.13 μM for human recombinant ACL); blocks lipid synthesis (IC50 = 8 μM in HepG2 cells). Displays no cytotoxicity up to a concentration of 50 μM. Lowers plasma glucose and triglycerides in a mouse model of hyperlipidemia. Orally bioavailable.
Specifications
Specifications
| Kemiskt namn eller material | BMS 303141 |
| Kvantitet | 10 mg |
| Formel vikt | 424.3 |
| Renhet | 0.98 |
| Molekylvikt (g/mol) | 424.29 |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?